# Task B26: Drug Synthesis Activities for SARS-CoV-2

> **NIH NIH N01** · RESEARCH TRIANGLE INSTITUTE · 2022 · $97,008

## Abstract

This task provides for lead identification, development, chemistry and synthesis services under the NIAID Preclinical Services for the Development of Interventional Agents Program.

## Key facts

- **NIH application ID:** 10703290
- **Project number:** 272201800002I-0-759302200001-1
- **Recipient organization:** RESEARCH TRIANGLE INSTITUTE
- **Principal Investigator:** BRUCE BLOUGH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $97,008
- **Award type:** —
- **Project period:** 2018-05-01 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10703290

## Citation

> US National Institutes of Health, RePORTER application 10703290, Task B26: Drug Synthesis Activities for SARS-CoV-2 (272201800002I-0-759302200001-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10703290. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*